Nutex Health Inc. Common Stock (NUTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NUTX trades at $121.54 with a market cap of $858.10M and a P/E ratio of 10.88. NUTX moved -3.70% today. Year to date, NUTX is -27.50%; over the trailing twelve months it is -31.41%. Its 52-week range spans $17.66 to $193.07. Analyst consensus is buy with an average price target of $237.50. Rallies surfaces NUTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nutex Health Q1 Revenue Up 2.2% to $216.5M; EPS Hits $6.52: Nutex Health’s Q1 revenue rose 2.2% to $216.5 million, driven by a 1.8% increase in its hospital division. Net income more than doubled to $46.8 million (EPS $6.52), operating cash flow climbed to $75.5 million, and net debt fell to $24.3 million.
| Metric | Value |
|---|---|
| Price | $121.54 |
| Market Cap | $858.10M |
| P/E Ratio | 10.88 |
| EPS | $11.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $193.07 |
| 52-Week Low | $17.66 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $875.26M |
| Net Income | $180.36M |
| Gross Margin | 50.76% |
2 analysts cover NUTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $237.50.